December 15, 2011
Shire LLC slapped Mylan Inc. with another patent suit over the attention deficit hyperactivity disorder drug Intuniv in West Virginia federal court Thursday, after Mylan changed its bid for regulatory approval of generic Intuniv to include three more dosage strengths.